PL2214021T3 - Zestaw do przewidywania powodzenia implantacji w zapłodnieniu wspomaganym - Google Patents

Zestaw do przewidywania powodzenia implantacji w zapłodnieniu wspomaganym

Info

Publication number
PL2214021T3
PL2214021T3 PL10162987T PL10162987T PL2214021T3 PL 2214021 T3 PL2214021 T3 PL 2214021T3 PL 10162987 T PL10162987 T PL 10162987T PL 10162987 T PL10162987 T PL 10162987T PL 2214021 T3 PL2214021 T3 PL 2214021T3
Authority
PL
Poland
Prior art keywords
kit
csf
implantation success
assisted fertilisation
predicting
Prior art date
Application number
PL10162987T
Other languages
English (en)
Inventor
Nathalie Lédée
Marie-Pierre Piccinni
Raoul Lombroso
Original Assignee
Femalon S P R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Femalon S P R L filed Critical Femalon S P R L
Publication of PL2214021T3 publication Critical patent/PL2214021T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL10162987T 2006-07-21 2007-07-18 Zestaw do przewidywania powodzenia implantacji w zapłodnieniu wspomaganym PL2214021T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83209406P 2006-07-21 2006-07-21
EP07787688A EP2049906B1 (en) 2006-07-21 2007-07-18 Assay and kit for predicting implantation success in assisted fertilisation
EP10162987.1A EP2214021B1 (en) 2006-07-21 2007-07-18 Kit for predicting implantation success in assisted fertilisation

Publications (1)

Publication Number Publication Date
PL2214021T3 true PL2214021T3 (pl) 2015-06-30

Family

ID=38529962

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10162987T PL2214021T3 (pl) 2006-07-21 2007-07-18 Zestaw do przewidywania powodzenia implantacji w zapłodnieniu wspomaganym
PL07787688T PL2049906T3 (pl) 2006-07-21 2007-07-18 Test i zestaw do przewidywania powodzenia zagnieżdżenia zarodka we wspomaganym zapłodnieniu

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL07787688T PL2049906T3 (pl) 2006-07-21 2007-07-18 Test i zestaw do przewidywania powodzenia zagnieżdżenia zarodka we wspomaganym zapłodnieniu

Country Status (21)

Country Link
US (1) US8211650B2 (pl)
EP (5) EP2857840B8 (pl)
JP (1) JP5052609B2 (pl)
KR (2) KR101482568B1 (pl)
CN (2) CN106199004B (pl)
AT (1) ATE468538T1 (pl)
AU (1) AU2007275112B2 (pl)
BR (1) BRPI0714494B1 (pl)
CA (1) CA2658665C (pl)
DE (1) DE602007006672D1 (pl)
DK (2) DK2214021T3 (pl)
EA (1) EA016348B1 (pl)
ES (4) ES2345571T3 (pl)
HK (2) HK1128760A1 (pl)
HR (2) HRP20100382T8 (pl)
MX (1) MX2009000569A (pl)
MY (1) MY150687A (pl)
NZ (1) NZ574135A (pl)
PL (2) PL2214021T3 (pl)
PT (2) PT2049906E (pl)
WO (1) WO2008009705A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338373B2 (en) 2003-10-24 2012-12-25 Nora Therapeutics, Inc. Method for reducing the risk of spontaneous abortion in a human female subject
EP2140875A1 (en) 2003-10-24 2010-01-06 Nora, LLC Compositions and methods for healthy pregnancy
US20090226397A1 (en) 2003-10-24 2009-09-10 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
US9176145B2 (en) 2006-07-21 2015-11-03 Femalon S.P.R.L. Kit for predicting implantation success in assisted fertilization
GB0806281D0 (en) * 2008-04-07 2008-05-14 Univ Leeds Markers of Oocyte viability
JP5902478B2 (ja) * 2008-05-01 2016-04-13 ザイモジェネティクス, インコーポレイテッド 血清中のBLyS/APRILヘテロ三量体レベルおよび診断方法における使用
WO2010126528A1 (en) * 2009-05-01 2010-11-04 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
WO2010151221A1 (en) * 2009-06-25 2010-12-29 Phase Holographic Imaging Phi Ab Analysis of ova or embryos with digital holographic imaging
WO2011000805A1 (en) 2009-06-29 2011-01-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Biomarkers of oocyte competency and method of use
US9753042B2 (en) * 2013-04-23 2017-09-05 Rosalind Franklin University Of Medicine And Science Kits for determining male fertility by measuring levels of a2V-ATPase, G-CSF, MIP 1 alpha, MCP-1, and methods and kits for improving reproductive outcomes in artificial insemination procedures
EP3126836A4 (en) * 2014-04-02 2017-11-08 Prince Henry's Insitute of Medical Research Trading as The Hudson Institute of Medical Research A prognostic assay for succes of assisted reproductive technology
CN104450904A (zh) * 2014-12-02 2015-03-25 柳州市妇幼保健院 利用颗粒细胞端粒长度来判断胚胎发育潜能的方法
AU2016330398B2 (en) * 2015-09-30 2022-11-10 Hudson Institute of Medical Research A method of treatment and prognosis
CN110361534B (zh) * 2018-03-26 2023-11-03 山大生殖研发中心有限公司 评估胚胎和预测体外受精成功率的化学标记物和其应用
RU2746644C1 (ru) * 2021-01-21 2021-04-19 Мекан Рахимбердыевич Оразов Способ оценки имплантационной состоятельности эндометрия при повторных неудачах имплантации, ассоциированных с хроническим эндометритом

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
ATE167301T1 (de) 1988-03-24 1998-06-15 Terrapin Tech Inc Gruppe von getrennten peptiden
JP3058673B2 (ja) * 1989-11-10 2000-07-04 株式会社明電舎 サイトカインの測定方法及びその測定用キット
GB9603326D0 (en) 1996-02-16 1996-04-17 Royal Free Hosp School Med Predictive assay
JP5271481B2 (ja) * 1999-09-08 2013-08-21 中外製薬株式会社 タンパク質溶液製剤およびその安定化方法
US6555660B2 (en) * 2000-01-10 2003-04-29 Maxygen Holdings Ltd. G-CSF conjugates
JP4444652B2 (ja) 2001-07-11 2010-03-31 マキシゲン・ホールディングズ・リミテッド G−csf結合体

Also Published As

Publication number Publication date
PL2049906T3 (pl) 2010-10-29
US20090312596A1 (en) 2009-12-17
EP2857840A1 (en) 2015-04-08
EP2857840B1 (en) 2017-06-14
ES2531853T3 (es) 2015-03-20
HRP20100382T1 (hr) 2010-08-31
NZ574135A (en) 2011-11-25
AU2007275112A1 (en) 2008-01-24
EP2214021A1 (en) 2010-08-04
PT2214021E (pt) 2015-03-11
DK2214021T3 (en) 2015-02-16
ES2634527T3 (es) 2017-09-28
EP3267198A1 (en) 2018-01-10
DE602007006672D1 (de) 2010-07-01
US8211650B2 (en) 2012-07-03
BRPI0714494B1 (pt) 2018-05-08
CN101495871A (zh) 2009-07-29
EP2049906B1 (en) 2010-05-19
KR20140040289A (ko) 2014-04-02
ES2345571T3 (es) 2010-09-27
EA016348B1 (ru) 2012-04-30
EP2049906A1 (en) 2009-04-22
JP2009544934A (ja) 2009-12-17
EP3627156A1 (en) 2020-03-25
EA200900210A1 (ru) 2009-06-30
ATE468538T1 (de) 2010-06-15
EP2214021B1 (en) 2015-01-07
WO2008009705A1 (en) 2008-01-24
HK1128760A1 (en) 2009-11-06
CN106199004B (zh) 2019-04-09
ES2754707T3 (es) 2020-04-20
HK1208529A1 (en) 2016-03-04
PT2049906E (pt) 2010-08-02
BRPI0714494A2 (pt) 2013-05-14
HRP20150251T1 (en) 2015-06-05
DK2049906T3 (da) 2010-07-05
CA2658665A1 (en) 2008-01-24
MY150687A (en) 2014-02-28
MX2009000569A (es) 2009-06-19
CA2658665C (en) 2017-09-26
AU2007275112B2 (en) 2012-07-12
EP3267198B1 (en) 2019-09-04
HRP20100382T8 (en) 2010-10-31
CN106199004A (zh) 2016-12-07
KR20090056986A (ko) 2009-06-03
EP2857840B8 (en) 2017-08-02
KR101482568B1 (ko) 2015-01-14
JP5052609B2 (ja) 2012-10-17

Similar Documents

Publication Publication Date Title
HRP20150251T1 (en) Kit for predicting implantation success in assisted fertilisation
EA201101141A1 (ru) Получение закрытой линейной днк
NZ598293A (en) Imaging and evaluating embryos, oocytes, and stem cells
BR112015022821A2 (pt) método para avaliar status renal em um indivíduo e kit de ensaio de diagnóstico
TW200730138A (en) Image analysis methods for gleno-humeral joint morphology
MX2021015876A (es) Analisis del transcriptoma de plasma materno mediante secuenciacion de arn en paralelo a gran escala.
DE602007012766D1 (de) Verfahren zur quantitativen cDNA-Analyse in Einzelzellen
EP2657697A3 (en) Methods for determining the risk of chromosomal abnormality in a fetus
WO2009125219A3 (en) Markers of oocyte viability
BR112012025022A2 (pt) "método de redução da fragmentação de dna em uma amostra de espermatozoides separados"
MX2014015000A (es) Metodos para aumentar el progreso genetico en una linea o raza de cerdo con celulas de esperma seleccionadas por sexo.
Tessaro et al. Transferability and inter-laboratory variability assessment of the in vitro bovine oocyte fertilization test
MX2012005388A (es) Reactivos y metodos para detectar globulos blancos pnh tipo ii y su identificacion como factores de riesgo para transtornos trombolicos.
WO2009059289A3 (en) Netrin-1 compositions and methods of use thereof
WO2010045323A3 (en) A novel sorting technology that allows for highly efficient selection of sperm without chromatin damage
RU2012149631A (ru) СПОСОБ ПОЛУЧЕНИЯ aRNA И СПОСОБ АНАЛИЗА ЭКСПРЕССИИ ГЕНА
BR112017007213A2 (pt) "processamento e utilização de fluidos do trato reprodutivo para melhorar a produção in vitro de embriões de mamífero"
Sepulveda et al. Comparison of a single medium with sequential media for culture of sibling human embryos to the blastocyst stage
RU2013135071A (ru) Способ определения адгезивности клеток крови
Todorova et al. Gene Panel in Human Cumulus Cells as Biomarker for Successful in vitro Procedures
PL399243A1 (pl) Sposób dostarczania próbki plynu ustrojowego do ukladu analizujacego
UA39101U (ru) Способ прогнозирования эффективности осеменения свиноматок замороженной-оттаявшей спермой
TEIXEIRA et al. Luteal volume and progesterone serum concentration in Santa Ines sheep sinchronize with GnRH in a long or a short protocols.
UA50356U (ru) Способ определения качества лабораторных культур паразитических перепончатокрылых энтомофагов
Eyries et al. Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension